Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1- and Th17-dependent GVHD within the gastrointestinal tract. Takahashi S, Inoue T, Ensbey KS, Legg SRW, et al. Blood 2026;147:2143-2155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takahashi S, Inoue T, Ensbey KS, Legg SRW, et al. Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1- and Th17-dependent GVHD within the gastrointestinal tract. Blood 2026;147:2143-2155.
PMID: 41662631